Print

HVTN 087

Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID), HIV Vaccine Trials Network (HVTN), Profectus
HIV-MAG ,VSV-Indiana HIV gag vaccine DNA gag-pol B, nef, tat, vif, env B; VSV replicating gag
HIV-MAG DNA
VSV-Indiana HIV gag vaccine Viral Vector - Replicating
IL-12 DNA adjuvant
USA 100
NCT01578889
http://clinicaltrials.gov/ct2/show/NCT01578889?term=hiv+vaccine&lup_s=03%2F18%2F2012&lup_d=30